In a 11-page document dated Sept 22, Janet Woodcock MD, director for the Center for DrugEvaluation and Research, explains why she decided to allow Avandia to continue to be on the market.
“I don’t think the answer on Zetia is in, ” said Dr. Robert J. Temple, director for the office of medical policy at the Center for DrugEvaluation and Research, which is part of the F.D.A.
“我认为关于 Zetia 还没有答案。” Robert J. Temple博士说,他是“药品评价和研究中心”的医药政策办公室主任,该中心隶属FDA。
3
The methodology and process can provide reference for other research of drugevaluation and intervention for children.